Q1 2026 Neuraxis Inc Earnings Call Transcript

May 12, 2026 / 01:00 PM GMT

Release Date Price: $8.27 (+1.47%)

Transcript 10-Q

Key Points

Positve

Neuraxis Inc (NRXS) reported an 80% year-over-year revenue growth for Q1 2026, reaching $1.6 million compared to $896,000 in Q1 2025.
The company saw a 33% increase in the average selling price of its IV stim device, indicating a positive reimbursement mix shift.
Neuraxis Inc (NRXS) has over 100 million covered lives, including a major national health insurer policy covering approximately 45 million health plan members.
The company has been awarded a federal supply schedule contract, enabling access to the U.S. Department of Veterans Affairs, which serves nearly 7 million active patients annually.
Neuraxis Inc (NRXS) is actively expanding its commercial team and infrastructure to support growth, including new hires in sales, marketing, and payer access roles.

Negative

Despite the introduction of a Category 1 CPT code, payer coverage adoption remains gradual and is a significant barrier to broader utilization.
The company reported a net loss of $1.8 million for Q1 2026, although this was a 23% improvement from the previous year.
Neuraxis Inc (NRXS) faces challenges in achieving consistent insurance coverage across a meaningful portion of their payer mix, which is crucial for scalable growth.
The company is experiencing delays in some state Medicaid programs loading the new CPT code on their fee schedules, affecting hospital activation.
Neuraxis Inc (NRXS) anticipates a one-time, non-recurring stock compensation charge in Q2 2026, which will impact financial results.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NRXS.A - Neuraxis Inc
Q1 2026 Neuraxis Inc Earnings Call
May 12, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Nuraxis First Quarter Fiscal Year 2026 Financial Results Conference Call.

All participants will be in listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touchtone phone.

To withdraw your question, please press star then two.

Please note this event is being recorded.

I'd now like to turn the conference over to Ben Champsion, Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.